Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.61B |
| 2 |
Microsoft
MSFT
|
+$1.17B |
| 3 |
Broadcom
AVGO
|
+$366M |
| 4 |
Merck
MRK
|
+$343M |
| 5 |
Meta Platforms (Facebook)
META
|
+$260M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$609M |
| 2 |
CMA
Comerica
CMA
|
+$512M |
| 3 |
CADE
Cadence Bank
CADE
|
+$422M |
| 4 |
Johnson & Johnson
JNJ
|
+$331M |
| 5 |
Western Digital
WDC
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.81% |
| 2 | Financials | 17.07% |
| 3 | Industrials | 12.55% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Healthcare | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1476
Mercantile Bank Corp
MBWM
$1.02B
| $52.2M | 0.01% |
1,032,888
+1,403
| +0.1% | +$72.1K |
2013 Q2
51 quarters
|
|
1477
Edgewell Personal Care
EPC
$1.23B
| $52.1M | 0.01% |
2,440,843
-174,214
| -7% | -$3.51M |
2013 Q2
51 quarters
|
|
1478
Avis
CAR
$3.75B
| $52M | 0.01% |
356,900
+17,074
| +5% | +$1.95M |
2013 Q2
51 quarters
|
|
1479
LeMaitre Vascular
LMAT
$1.83B
| $52M | 0.01% |
476,335
+490
| +0.1% | +$46.7K |
2013 Q2
51 quarters
|
|
1480
Independence Realty Trust
IRT
$3.42B
| $51.7M | 0.01% |
3,473,797
+134,364
| +4% | +$2.21M |
2015 Q3
42 quarters
|
|
1481
Safety Insurance
SAFT
$1.52B
| $51.7M | 0.01% |
711,806
+3,319
| +0.5% | +$252K |
2013 Q2
51 quarters
|
|
1482
Denali Therapeutics
DNLI
$3.28B
| $51.7M | 0.01% |
2,692,175
+317,872
| +13% | +$6.32M |
2019 Q2
27 quarters
|
|
1483
Royalty Pharma
RPRX
$25.7B
| $51.7M | 0.01% |
1,078,365
-1,233,763
| -53% | -$54M |
2021 Q1
20 quarters
|
|
1484
PJT Partners
PJT
$3.59B
| $51.6M | 0.01% |
369,377
+9,337
| +3% | +$1.47M |
2017 Q2
35 quarters
|
|
1485
COPT Defense Properties
CDP
$3.77B
| $51.5M | 0.01% |
1,682,296
+25,026
| +2% | +$778K |
2013 Q2
51 quarters
|
|
1486
Enphase Energy
ENPH
$4.34B
| $51.5M | 0.01% |
1,361,157
+373,212
| +38% | +$15.5M |
2019 Q2
27 quarters
|
|
1487
Vita Coco
COCO
$3.3B
| $51.4M | 0.01% |
1,073,413
+61,950
| +6% | +$3.38M |
2023 Q1
12 quarters
|
|
1488
Transmedics
TMDX
$2.73B
| $51.4M | 0.01% |
516,679
+26,969
| +6% | +$3.52M |
2024 Q3
6 quarters
|
|
1489
Beam Therapeutics
BEAM
$2.52B
| $51.3M | 0.01% |
2,154,575
+206,696
| +11% | +$5.74M |
2021 Q1
20 quarters
|
|
1490
Clarivate
CLVT
$1.02B
| $51.1M | 0.01% |
20,216,351
-1,108,455
| -5% | -$2.84M |
2021 Q2
19 quarters
|
|
1491
German American Bancorp
GABC
$1.83B
| $51M | 0.01% |
1,219,958
+31,627
| +3% | +$1.31M |
2013 Q2
51 quarters
|
|
1492
Heritage Financial
HFWA
$1.14B
| $50.9M | 0.01% |
1,956,477
-22,133
| -1% | -$575K |
2013 Q2
51 quarters
|
|
|
BELFB
1493
Bel Fuse Inc Class B
BELFB
$3.64B
| $50.9M | 0.01% |
256,833
+1,992
| +0.8% | +$416K |
2013 Q2
51 quarters
|
|
1494
Solventum
SOLV
$14.9B
| $50.6M | 0.01% |
774,683
+236,659
| +44% | +$17.6M |
2024 Q2
7 quarters
|
|
1495
Under Armour
UAA
$1.99B
| $50.4M | 0.01% |
8,531,173
+1,285,384
| +18% | +$8.33M |
2013 Q2
51 quarters
|
|
1496
News Corp Class B
NWS
$17B
| $50.2M | 0.01% |
1,761,977
+46,837
| +3% | +$1.32M |
2013 Q3
50 quarters
|
|
1497
QuidelOrtho
QDEL
$712M
| $50.1M | 0.01% |
3,048,768
+212,481
| +7% | +$5.22M |
2013 Q2
51 quarters
|
|
1498
Guidewire Software
GWRE
$12.7B
| $50M | 0.01% |
334,635
-19,842
| -6% | -$3.02M |
2013 Q2
51 quarters
|
|
1499
Churchill Downs
CHDN
$5.21B
| $49.9M | 0.01% |
555,825
-8,688
| -2% | -$825K |
2013 Q2
51 quarters
|
|
|
TRST
1500
Trustco Bank Corp NY
TRST
$932M
| $49.8M | 0.01% |
1,137,504
-5,359
| -0.5% | -$234K |
2013 Q2
51 quarters
|
|
Similar funds
Dimensional Fund Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Dimensional Fund Advisors held 3,312 positions worth $481B, up 0.98% from $477B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q1 2026 filing shows 72 new, 1,935 increased, 1,135 reduced and 97 closed positions. Its largest new stake was Versant Media Group: 1,127,961 shares worth $41.7M. The largest sale was AstraZeneca, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2026 buy was Versant Media Group: 1,127,961 shares worth $41.7M.
- Dimensional Fund Advisors added most to Amazon in Q1 2026, an estimated $1.61B increase.
- Dimensional Fund Advisors's biggest Q1 2026 reduction was Johnson & Johnson, cutting an estimated $331M.
- Dimensional Fund Advisors fully exited AstraZeneca in Q1 2026, selling an estimated $609M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $481B portfolio in Q1 2026.
- Dimensional Fund Advisors opened 72 new positions and closed 97 in Q1 2026.
- Dimensional Fund Advisors's portfolio value rose 0.98% quarter-over-quarter to $481B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.